Cargando…
Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer
Prostate cancer (PCa) poses a high risk to older men and it is the second most common type of male malignant tumor in western developed countries. Additionally, there is a lack of effective therapies for PCa at advanced stages. Novel treatment strategies such as adenovirus-mediated gene therapy and...
Autores principales: | Cai, Zhonglin, Lv, Haidi, Cao, Wenjuan, Zhou, Chuan, Liu, Qiangzhao, Li, Hui, Zhou, Fenghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865813/ https://www.ncbi.nlm.nih.gov/pubmed/28901490 http://dx.doi.org/10.3892/mmr.2017.7487 |
Ejemplares similares
-
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
por: Nguyen, Tien V, et al.
Publicado: (2018) -
Efficacy and tolerability of combination therapy with alpha-blockers and phosphodiesterase-5 inhibitors compared with monotherapy for lower urinary tract symptoms: Protocol for a systematic review and network meta-analysis
por: Qiangzhao, Liu, et al.
Publicado: (2020) -
Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
por: Panek, Wojciech K., et al.
Publicado: (2017) -
Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies
por: Cunliffe, Tabitha G., et al.
Publicado: (2020) -
The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
por: Tate, Sophia J., et al.
Publicado: (2021)